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INTRODUCTION
Metanephric adenoma (MA), also designated nephrono-
genic nephroma or renal epithelial tumor resembling
immature nephron, has just been recently recognized as a
special type of benign renal epithelial tumor. Only few
reports are found in the literature regarding this rare renal
tumor. The purpose of this paper is to describe our clinical,
imaging and histological / immunohistochemical observa-
tions of MA diagnosed in two patients and compare these
data to previous information reported in medical databases.
CASE REPORT
The first case refers to a 70-years-old female patient, who
except by systemic arterial hypertension was completely
healthy. During routine examinations, a mass of 4.5 cm
located on the lower third of her right kidney was
incidentally found. At that time, the patient presented only
low-grade fever and weakness for about two weeks.
Abdominal ultrassonography (USG) showed hypoechoec
mass with solid aspect and irregular limits. It was
heterogeneous and exofitic, containing septation and cystic
areas in its interior. Magnetic resonance imaging (MRI)
showed a solid mass 5.2 cm for its higher dimension located
in right kidney with same hemorrhagic foci and no sign of
peri-renal invasion (Figure 1). Also, simple renal cysts were
evidenced. The patient was submitted to a successful partial
nephrectomy by open surgery, evolving uneventfully.
Pathologic examination of surgical specimen revealed a
firm lesion of light brown tissue with reticulated central
area and clear delimitation from the adjacent parenchyma.
Microscopic evaluation showed no cellular atypical or
mitotic activity. Peri-renal adipose tissue was free from
neoplasic invasion.
The second patient was a 23-year-old man with no
previous heath problem, who presented with flank pain
for one month. Abdominal USG showed a 464 cm nodular,
solid and heterogenic lesion with hyperecogenic areas and
exofitic characteristics in the lower third of right renal
parenchyma. Computed tomography (CT) confirmed the
presence of a 4 cm expansive tumoral formation with
intermediate attenuation and minimum venous contrast
enhancing at that anatomic site (Figure 2). Partial nephrect-
omy was again the therapeutic choice. The patient evolved
well but an arterial-venous fistula clinically manifested by
hematuria was diagnosed in post-operative (PO) day five.
The fistula was successfully embolized by arteriography
and no other complications occurred. Immunohistochemical
study employing incubation of histological cuts with mono
and polyclonal antibodies (panels) showed a profile focally
and positive to WT-1, EMA and CK7.
Both patients are free of neoplasic disease with no signs of
recurrence after 2 years of follow up.
DISCUSSION
MA is a renal tumor with benign behavior. The
classification is based on a combination of histological,
immunohistochemical, and genetic features. Most small MA
tumors are well circumscribed, firm, and white; larger
tumors may be hemorrhagic and softer.
The cytology of a few cases has been described1 and is
composed of tight, short papillae and loose sheets of cells
with scant cytoplasm, round nuclei, fine chromatin and rare
small nucleoli. By analyzing all described findings at
immunohistochemical and lectin histochemical studies,
MA has shown reactivity for keratin (CK7 is the most
common), CD 57, vimentin, S-100 protein, EMA, lysozyme,
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Figure 1 - MRI - solid mass 5.2 cm in higher dimension located in
right kidney with same hemorrhagic foci and no sign of perirenal
invasion
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a-1-antitrypsin, PNA, DBA, SBA and WT-1.2 It seems that,
despite the variability, CK7 focally positive is a rule. In our
second case, immunohistochemic examination revealed
WT-1, EMA and CK7 locally positive.
Unlike renal adenoma, which is by definition ,5 mm in
diameter, MA can grow to a large size. The diameter of MA
ranges from 6 to 200 mm2. Our findings were renal tumors
of 40 and 45 mm. All MA reported, except one,3 behaved in
a benign way with no metastatic findings or local recurrence
after surgical removal, showing no evidence of cellular
atypical or mitotic activity.2 Similar fact was observed for
our two patients. For their special findings in MA variants,
some authors deserve brief comment. In 2000, Renshaw et al
3 presented the only reported case of a metastatic disease
from a typical MA occurring in a 7 year old child, but no
death related to the tumor has been demonstrated.
Clinical manifestations related to MA are very unspecific
and sometimes even absent, being the majority of these
renal tumors incidentally found.4 In 1995, four of eight cases
reported by Nonomura et al5 were found with no signs or
symptoms and two presented only a tumoral mass. In the
same year, Jones et al6 reported one tumor found only at
autopsy and six tumors discovered during other pathologi-
cal investigation. When present, signs and symptoms
include abdominal or flank pain, hematuria, palpable mass,
hypertension and fever. Our cases presented some of these
clinical findings.
At present there are only few reports regarding the
imaging findings of MA. Some authors found adenomas to
be hyperechoic at USG.7,8 MA has been described to show
enhancement on contrast CT, but angiography reveals
neither neovascularization nor tumor staining. 7,8 On both
T1- and T2-weighted MR images, the tumor is represented
as an isointense mass.5,7 On the imaging findings of MA,
hypovascularity and frequent calcification may be rather
characteristic. Bastide et al9 reported their imaging findings
in nine patients, describing MA as a lesion with no vascular
flow on color Doppler USG, presence of calcifications, and
minimal enhancement in contrast CT. It is possible to realize
that MA has same common findings, however none is so
specific neither can exclude malignity.
Most reports describe total nephrectomy as gold standard
treatment for MA, but partial nephrectomy must be
considered a good option. Nowadays, it is known that
partial nephrectomy is indicated even to malignant tumors
and even large masses (bigger than 4 cm) can be ressected
without prejudice to the oncological results. In 2000, Kosugi
et al.10 performed partial nephrectomy for a 32 years old
female patient who presented with a right renal MA of
1.5 cm at abdominal USG examination at a routine medical
check up. Our two patients were also treated with partial
nephrectomy, procedure with better renal function preser-
vation, without compromising the patient’s survival.
Further advance in reducing patient morbidity may be
achieved by laparoscopic nephrectomy as reported by Ebine
et al.11 in 2004 for MA treatment in a 31 years old female
patient with a left renal mass of 4.5 cm detected incidentally
during an abdominal ultrasound examination. Three years
latter, Kumar et al12 reported a laparoscopic partial
nephrectomy as treatment for MA in a 47-year-old patient.
In the biggest MA series reported, Bastide et al9 performed
four radical and five partial nephrectomies. In this paper,
authors suggest a preoperative diagnostic biopsy, a partial
nephrectomy or active surveillance. We believe, that biopsy
should be reserved to cases where patient refuse or does not
have clinical conditions for surgery or less invasive
procedure shall be tried, such as cryotherapy.
It is possible to realize that MA treatment has evolved as
well as others renal tumors approach, and partial nephrect-
omy should be remembered as an option (Table 1).
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